ExonHit Therapeutics Inc. and Beijing Genomics Institute (BGI) Announce Successful Completion of a Promising Next-Generation Sequencing Project
PARIS--(BUSINESS WIRE)--Regulatory News: Exonhit (Paris:ALEHT), a biotech company focused on personalized medicine, and BGI, the world’s largest genome organization, are pleased to announce the successful completion of a project dedicated to expanding Exonhit’s Genome-Wide SpliceArrayTM to an additional strategic preclinical animal model species.